- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 213/64 - One oxygen atom attached in position 2 or 6
Patent holdings for IPC class C07D 213/64
Total number of patents in this class: 935
10-year publication summary
|
85
|
67
|
74
|
78
|
58
|
65
|
64
|
51
|
47
|
15
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Epizyme, Inc. | 383 |
25 |
| Abbvie Inc. | 1808 |
19 |
| Bristol-myers Squibb Company | 5080 |
17 |
| F. Hoffmann-La Roche AG | 7958 |
15 |
| Boehringer Ingelheim International GmbH | 4629 |
15 |
| Mitsui Chemicals Agro, Inc. | 93 |
14 |
| Bayer Pharma AG | 1096 |
12 |
| Takeda Pharmaceutical Company Limited | 2961 |
12 |
| Inflazome Limited | 92 |
12 |
| Nippon Soda Co., Ltd. | 890 |
10 |
| Eisai R&D Management Co., Ltd. | 1304 |
10 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
9 |
| Calico Life Sciences LLC | 71 |
9 |
| Unigen, Inc. | 118 |
8 |
| Pfizer Inc. | 3322 |
7 |
| Bayer Cropscience AG | 2241 |
7 |
| Gilead Sciences, Inc. | 1879 |
7 |
| Shionogi & Co., Ltd. | 914 |
7 |
| Merck Sharp & Dohme LLC | 3689 |
7 |
| Genentech, Inc. | 3742 |
6 |
| Other owners | 707 |